National Reference Centre for Parasitology

The National Centre for Parasitology (Serology) is one of the external reference laboratories in Canada funded in part by the Laboratory Centre for Disease Control, by the Montreal General Hospital, and by the McGill Centre for Tropical Diseases.

Click to Immunodiagnostic Services.

Mission


To provide reference diagnostic services in Serology for Parasitic Diseases
To provide consulting services to the Laboratory Centre for Disease Control, provincial  laboratories, and clinical parasitologists
To develop a research and development program
            

Organization and Management


The NRCP is a unit in the J.D. MacLean Centre for Tropical Diseases at McGill Universitys funded in part by the LCDC and by the Montreal General Hospital, McGill Centre for Tropical Diseases

Director-NRCP    Dr. Brian Ward
Laboratory Director-NRCP    Dr. Momar Ndao
Technologist-NRCP    Favio Vasques Canargo, Bijoya Nath-Chowdhury

RRCP advisory committee:
Dr. Brian Ward, Director NRCP
Dr. Momar Ndao, Laboratory Director NRCP
Dr. M Libman, Director J.D. MacLean Centre for Tropical Diseases at McGill University Dr. Jean Joly, Director LSPQ
Dr. Michel Couillard, LSPQ
Dr. Theresa Gyorkos, Division of Clinical Epidemiology
Louise Trudel, Chief Parasitology Technologist, LSPQ
                                     

Location


The address of the National Reference Centre for Parasitology  is:

National Reference Centre for Parasitology
Montreal General Hospital
Research Institute room R3-137
1650 Cedar Avenue
Montreal, Quebec H3G 1A4
Canada
             
Dr Momar Ndao can be reached at momar.ndao [at] mcgill.ca
Tel: (514) 934-8347

Medical questions may also be directed to Dr. Brian Ward (director NRCP), telephone (514) 934-1934, local 42810, Fax (514) 934-8347,  or email  Dr. Michael Libman (Director)michael.libman [at] muhc.mcgill.ca(director) telephone (514) 934-8049, Fax (514) 934-8224.

Research Interests
 

*Establishment of a highly defined "gold standard" serum bank
*Quality control of current assays
*Evaluation of commercially available new diagnostic tests
*Implantation of important assays already established elsewhere with the collaboration of Centers for Diseases Control and Prevention (CDC), Atlanta, USA
*Development of new assays for parasite diagnosis
*Epidemiologic studies in parasitology